Petrus Järvinen

6PUBLICATIONS
28CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 04, 2026
Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models.

Neja Sirc, Johannes Smolander, Anita N Kumari

|Jul 24, 2023
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.

Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen

|Jun 17, 2022
Active surveillance versus initial surgery in the long-term management of Bosniak IIF-IV cystic renal masses.

Lassi Luomala, Juhana Rautiola, Petrus Järvinen

|Jan 10, 2022
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma.

Moon Hee Lee, Petrus Järvinen, Harry Nísen

|Sep 14, 2020
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition.

Victor Cervera-Carrascon, Dafne C A Quixabeira, Joao Manuel Santos

|Aug 05, 2020
Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma.

Sara V Tornberg, Harry Nisen, Petrus Järvinen

Pageof 1

Frequent Collaborators

5 joint publications

Tuomas Mirtti

3 joint publications

Moon Hee Lee

3 joint publications

Satu Mustjoki

3 joint publications

Anna S Kreutzman